Systematic review finds potential in glutamatergic medications for OCD treatment

A systematic review and meta-analysis from the Harvard T.H. Chan School of Public Health reported a large effect of glutamatergic medications on improving symptoms of obsessive-compulsive and related disorders (OCRDs). The study evaluated outcomes across 27 randomized clinical trials, finding significant benefits, particularly for obsessive-compulsive disorder (OCD).